Antoine I.
- Country
- France
- Department
- Oncologie
Research Overview
- Phase 1 Study of SHP2 Inhibitor BBP-398 and KRAS-G12C Inhibitor Sotorasib in Advanced Solid Tumors with KRAS-G12C Mutation
- Safety and Efficacy Evaluation of RO7759065 with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors
- Comparative Study of Onivyde from Two Production Sites in Adults with Metastatic Pancreatic Adenocarcinoma
Data & Insights
Has run more than one trial at 174 of 286 partner sites.
Specializations
Advanced Cancer Treatment
Specializes in investigating novel therapeutic approaches for advanced and metastatic solid tumors, with particular emphasis on developing innovative treatment strategies for patients with limited options.
- Solid Tumor Therapies
- Metastatic Disease Management
- Combination Treatment Approaches
Focuses on evaluating new therapeutic compounds and immunotherapy combinations for various cancer types.
Sarcoma Research
Demonstrates significant expertise in treating various forms of sarcoma, including studies on soft tissue sarcomas, osteosarcoma, and gastrointestinal stromal tumors.
- Advanced Sarcoma Treatments
- Rare Sarcoma Subtypes
- Multimodal Therapy Approaches
Investigates both conventional chemotherapy and targeted therapeutic options for sarcoma patients.
Targeted Oncology
Conducts research on molecularly targeted therapies for specific cancer mutations, including studies on BRAF, NRAS, and HER2-expressing tumors.
- Mutation-Specific Treatments
- Personalized Medicine Approaches
- Novel Drug Development
Explores innovative therapeutic strategies based on specific genetic markers and molecular pathways.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.